Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,994 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.

NCT01908621

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch Gliwice, Poland

View Trial Details

Completed

Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL

NCT01686165

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

An Open-label Phase II Study of Lorvotuzumab Mertansine

NCT02420873

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Hematologic Diseases, +21 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)

NCT00779584

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

NCT00416312

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +39 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

NCT00369681

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma

NCT00169143

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Hôpital Henri Mondor Créteil, France

Service d'Hématologie Clinique - CHU Le Bocage Dijon, France

Hôpital Saint Louis Paris, France

Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite, France

View Trial Details

Completed

Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma

NCT00915096

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: CHU - Besançon Besançon, France

CHU Avicenne Bobigny, France

Centre Bergognié Bordeaux, France

Hôpital Henri Mondor Créteil, France

View all 22 locations

View Trial Details

Completed

Lenalidomide and R-CHOP in B-cell Lymphoma

NCT00901615

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: CHU de Dijon Dijon, France

CHRU Lille Lille, France

CHU Lyon Sud Pierre-Bénite, France

Centre Henri Becquerel Rouen, France

View Trial Details

Completed

Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma

NCT00169468

Conditions: B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hôpital Saint-Louis Paris, Paris 10, France

Institut Gustave Roussy Villejuif, Villejuif Cedex, France

Hôpital Henri Mondor Créteil, France

Hôpital Lyon Sud Pierre-Bénite, France

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions